Neuro-Ophthalmology News

Japan’s Ministry of Health, Labour and Welfare approved Enspryng to treat adults and children with neuromyelitis optica spectrum disorder, according to a press release.

Viela Bio has received FDA approval for Uplizna, an intravenous treatment for neuromyelitis optica spectrum disorder in certain adults.

Defining objective criteria for glaucomatous optic neuropathy, rather than relying on clinical assessments alone, is needed for comparing outcomes across clinical research studies, according to a speaker at the virtual Association for Research in Vision and Ophthalmology meeting.

Patients treated with satralizumab as monotherapy were at less risk for neuromyelitis optica spectrum disorder relapse compared with patients treated with placebo, according to a study.

by Michael Steiner, PT, DPT

People with Parkinson’s disease have a higher prevalence of ophthalmologic symptoms than those without the disease, according to research published in Neurology, the medical journal of the American Academy of Neurology.

Neuro-ophthalmologic function is affected by subconcussive head impacts which may affect individuals participating in contact sports, according to a randomized clinical trial.

WASHINGTON — Patients with glaucoma may have an increased prevalence of certain central neurodegenerative diseases, such as various types of non-Alzheimer’s dementia, according to a speaker here.

Nonmydriatic fundus photography after suspected minor stroke or transient ischemic attack was able to differentiate between actual stroke and mimics, according to findings from the FOTO-ED TIA study presented at the International Stroke Conference.

by Shirley Ha, HBSc, OD, FCOVD